D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$301M |
| 3 |
Bausch Health
BHC
|
+$273M |
| 4 |
SPDR Gold Trust
GLD
|
+$231M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| 1 |
LyondellBasell Industries
LYB
|
+$414M |
| 2 |
AGN
ALLERGAN INC
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$349M |
| 4 |
IBM
IBM
|
+$254M |
| 5 |
Microsoft
MSFT
|
+$247M |
Sector Composition
| 1 | Energy | 12.35% |
| 2 | Consumer Discretionary | 12.14% |
| 3 | Technology | 11.81% |
| 4 | Healthcare | 10.57% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
American Axle
AXL
$704M
| $870K | ﹤0.01% |
+33,684
| New | +$870K |
|
|
JBTM
1802
JBT Marel Corporation
JBTM
$7.09B
| $867K | ﹤0.01% |
24,261
+5,644
| +30% | +$202K |
|
1803
Banc of California
BANC
$2.65B
| $865K | ﹤0.01% |
70,304
+26,276
| +60% | +$323K |
|
|
OB
1804
DELISTED
Onebeacon Insurance Group Ltd
OB
| $865K | ﹤0.01% |
56,861
+21,417
| +60% | +$326K |
|
1805
British American Tobacco
BTI
$123B
| $859K | ﹤0.01% |
16,562
+7,810
| +89% | +$405K |
|
1806
Inovio Pharmaceuticals
INO
$140M
| $856K | ﹤0.01% |
8,747
-4,236
| -33% | -$415K |
|
1807
Universal Technical Institute
UTI
$1.48B
| $855K | ﹤0.01% |
89,077
-1,980
| -2% | -$19K |
|
1808
Plug Power
PLUG
$1.66B
| $854K | ﹤0.01% |
+329,570
| New | +$854K |
|
|
RTN
1809
DELISTED
Raytheon Company
RTN
| $852K | ﹤0.01% |
7,799
-143,947
| -95% | -$15.7M |
|
1810
AutoZone
AZO
$71.1B
| $848K | ﹤0.01% |
1,244
-3,619
| -74% | -$2.47M |
|
|
TC
1811
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $848K | ﹤0.01% |
642,601
-58,458
| -8% | -$77.1K |
|
|
PNNT
1812
Pennant Park Investment Corp
PNNT
$469M
| $847K | ﹤0.01% |
+93,579
| New | +$847K |
|
1813
Associated Banc-Corp
ASB
$4.36B
| $846K | ﹤0.01% |
45,482
-145,127
| -76% | -$2.7M |
|
1814
Renasant Corp
RNST
$3.67B
| $846K | ﹤0.01% |
28,147
+5,612
| +25% | +$169K |
|
|
CCXI
1815
DELISTED
ChemoCentryx, Inc.
CCXI
| $844K | ﹤0.01% |
111,770
+10,612
| +10% | +$80.1K |
|
|
JRN
1816
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $844K | ﹤0.01% |
56,929
-53,461
| -48% | -$793K |
|
1817
UGI
UGI
$7.38B
| $843K | ﹤0.01% |
+25,867
| New | +$843K |
|
|
GHDX
1818
DELISTED
Genomic Health, Inc.
GHDX
| $842K | ﹤0.01% |
27,573
+15,489
| +128% | +$473K |
|
|
PERY
1819
DELISTED
Perry Ellis International Inc
PERY
| $842K | ﹤0.01% |
36,343
+13,724
| +61% | +$318K |
|
1820
Carriage Services
CSV
$652M
| $841K | ﹤0.01% |
35,222
+2,982
| +9% | +$71.2K |
|
1821
Medtronic
MDT
$118B
| $841K | ﹤0.01% |
10,785
+453
| +4% | +$35.3K |
|
1822
Magnite
MGNI
$3.4B
| $840K | ﹤0.01% |
46,891
-261
| -0.6% | -$4.68K |
|
1823
Brunswick
BC
$4.23B
| $835K | ﹤0.01% |
16,228
+7,915
| +95% | +$407K |
|
1824
Talphera
TLPH
$17.4M
| $835K | ﹤0.01% |
10,808
-1,108
| -9% | -$85.6K |
|
1825
Quanex
NX
$697M
| $823K | ﹤0.01% |
41,693
+1,536
| +4% | +$30.3K |
|